Oracle Corporation (NYSE:ORCL – Get Free Report) CEO Clayton Magouyrk sold 10,000 shares of the stock in a transaction dated Monday, February 9th. The stock was sold at an average price of $155.23, for a total value of $1,552,300.00. Following the sale, the chief executive officer owned 134,030 shares of the company’s stock, valued at approximately $20,805,476.90. The trade was a 6.94% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Oracle Trading Down 1.7%
Shares of NYSE:ORCL traded down $2.71 during midday trading on Wednesday, reaching $157.18. The company’s stock had a trading volume of 24,506,309 shares, compared to its average volume of 28,218,859. The firm has a market capitalization of $451.61 billion, a price-to-earnings ratio of 29.55, a PEG ratio of 1.37 and a beta of 1.64. The company has a debt-to-equity ratio of 3.28, a quick ratio of 0.91 and a current ratio of 0.91. The firm has a 50 day moving average price of $187.05 and a two-hundred day moving average price of $232.85. Oracle Corporation has a fifty-two week low of $118.86 and a fifty-two week high of $345.72.
Oracle (NYSE:ORCL – Get Free Report) last released its earnings results on Wednesday, December 10th. The enterprise software provider reported $2.26 EPS for the quarter, topping the consensus estimate of $1.64 by $0.62. The business had revenue of $16.06 billion during the quarter, compared to analysts’ expectations of $16.19 billion. Oracle had a return on equity of 70.60% and a net margin of 25.28%.The firm’s revenue was up 14.2% on a year-over-year basis. During the same quarter last year, the firm posted $1.47 earnings per share. As a group, analysts forecast that Oracle Corporation will post 5 earnings per share for the current year.
Oracle Dividend Announcement
Wall Street Analysts Forecast Growth
A number of equities research analysts have commented on the stock. BMO Capital Markets reduced their price target on shares of Oracle from $270.00 to $205.00 and set an “outperform” rating for the company in a report on Wednesday, February 4th. Wells Fargo & Company assumed coverage on shares of Oracle in a research report on Wednesday, December 3rd. They set an “overweight” rating and a $280.00 price objective on the stock. Oppenheimer reaffirmed a “market perform” rating on shares of Oracle in a research report on Thursday, December 11th. KeyCorp dropped their price target on Oracle from $350.00 to $300.00 and set an “overweight” rating on the stock in a research note on Thursday, December 11th. Finally, Stephens raised their price objective on Oracle from $208.00 to $331.00 and gave the company an “equal weight” rating in a research note on Friday, October 17th. Three investment analysts have rated the stock with a Strong Buy rating, twenty-six have given a Buy rating, eleven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $292.43.
Read Our Latest Research Report on Oracle
Key Stories Impacting Oracle
Here are the key news stories impacting Oracle this week:
- Positive Sentiment: CMS selects Oracle Cloud Infrastructure to support its modernization initiative — a material federal win that validates OCI for mission‑critical workloads and likely supports backlog and OCI demand. Oracle Cloud Infrastructure to Support Centers for Medicare and Medicaid’s Modernization Initiative
- Positive Sentiment: Oracle rolled out AI agents for Fusion Apps and highlighted strong cloud revenue growth (cloud +34%, RPO surge), reinforcing the company’s AI monetization narrative and recurring SaaS revenue momentum. Oracle Unveils AI Agents for Fusion Apps: Will it Boost Prospects?
- Positive Sentiment: DA Davidson and other firms upgraded ORCL recently, sparking a sharp short‑covering rally earlier in the week and providing a near‑term technical lift. DA Davidson Upgrades Oracle (NYSE:ORCL) to “Buy”
- Positive Sentiment: Renewed optimism around OpenAI exposure (and other AI partner activity) has supported investor sentiment that Oracle can capture meaningful AI cloud demand. Oracle (ORCL) gets fresh boost from optimism around OpenAI exposure
- Neutral Sentiment: Oracle Health customer wins (Hillsboro Health) and other product launches show steady commercial traction in healthcare and supply chain—positive for execution but smaller in near‑term revenue impact. Hillsboro Health Chooses AI-Powered Oracle Health Solutions to Help Advance Patient Care, Optimize Operations
- Neutral Sentiment: Short interest rose in January (shares sold short increased ~19.5% month‑over‑month). That amplifies volatility risk—could fuel squeezes or further downside depending on flows.
- Negative Sentiment: Multiple securities‑fraud class actions and shareholder alerts were filed this week (several law firms notifying investors), creating legal overhang and potential settlement risk that is weighing on the stock. Oracle Corporation Sued for Securities Law Violations – Contact The Gross Law Firm Before April 6, 2026 to Discuss Your Rights – ORCL Oracle Corporation (ORCL) Investors: Kessler Topaz Meltzer & Check, LLP Announces Lawsuit
- Negative Sentiment: Some sell‑side and media skepticism: Melius downgraded or lowered ratings citing AI monetization uncertainty, and high‑profile commentators flagged balance‑sheet concerns—both contributed to intraday selling pressure. Melius Downgrades Oracle (ORCL) to Hold Jim Cramer on Oracle (ORCL): “I Don’t Like What They’re Doing to Their Balance Sheet”
Institutional Trading of Oracle
Institutional investors and hedge funds have recently modified their holdings of the stock. PFC Capital Group Inc. boosted its position in shares of Oracle by 26.6% during the fourth quarter. PFC Capital Group Inc. now owns 3,943 shares of the enterprise software provider’s stock valued at $768,000 after buying an additional 828 shares during the last quarter. Legacy Capital Wealth Management LLC bought a new position in Oracle during the 4th quarter valued at $250,000. Barrow Hanley Mewhinney & Strauss LLC boosted its holdings in Oracle by 4.2% during the 4th quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 1,624,781 shares of the enterprise software provider’s stock worth $316,686,000 after acquiring an additional 65,998 shares during the last quarter. Empowered Funds LLC grew its stake in shares of Oracle by 6.7% in the 4th quarter. Empowered Funds LLC now owns 171,050 shares of the enterprise software provider’s stock worth $33,339,000 after acquiring an additional 10,804 shares in the last quarter. Finally, Meeder Advisory Services Inc. grew its stake in shares of Oracle by 5.5% in the 4th quarter. Meeder Advisory Services Inc. now owns 43,200 shares of the enterprise software provider’s stock worth $8,420,000 after acquiring an additional 2,254 shares in the last quarter. 42.44% of the stock is owned by hedge funds and other institutional investors.
About Oracle
Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.
Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.
Featured Articles
- Five stocks we like better than Oracle
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.
